PCI Pharma Services announced that it made a series of infrastructure investments to deepen its sterile fill-finish and advanced drug delivery capabilities.
Philadelphia-based PCI says its latest investments come as part of a broader commitment exceeding $1 billion. Its investment spans across its U.S. and European operations. The company hopes to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch.
PCI’s latest investment follows its 2024 expansion plans in Rockford, Illinois. At the core of its latest plan is a $100 million project in San Diego. This includes a high-speed isolator filling line for ready-to-use prefilled syringes and cartridges…